Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

被引:163
作者
Puoti, M
Bonacini, M
Spinetti, A
Putzolu, V
Govindarajan, S
Zaltron, S
Favret, M
Callea, F
Gargiulo, F
Donato, F
Carosi, G
机构
[1] Azienda Osped Spedali Civili, Clin Malattie Infett & Trop, Serv Anat Pathol, I-25123 Brescia, Italy
[2] Univ Brescia, Clin Malattie Infett & Trop, Brescia, Italy
[3] Univ Brescia, Cattedra Anat Patol, Brescia, Italy
[4] Univ Brescia, Ist Microbiol, Brescia, Italy
[5] Univ Brescia, Cattedra Igiene, Brescia, Italy
[6] Univ So Calif, Keck Sch Med, Los Angeles, CA USA
[7] Univ So Calif, Keck Sch Med, Downey, CA USA
关键词
D O I
10.1086/317644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A total of 204 patients with liver biopsy-proven hepatitis C virus (HCV) infection, 84 with and 120 without human immunodeficiency virus (HIV) coinfection, were studied, to evaluate variables possibly associated with the stage of liver fibrosis. All patients were injection drugs users, with a mean age of 32 years and an estimated duration of HCV infection of 12 years. Twenty-four patients (11%) had many fibrous septa with (5%) or without (6%) cirrhosis, 56 (27%) had few fibrous septa, and 124 (60%) had no fibrous septa. In all patients, an association was found between CD4 cell counts <500 cells/mm(3) and the presence of many fibrous septa (odds ratio, 3.2; P=.037), independent of HIV infection and other factors. These results suggest that HIV infection-induced CD4 depletion is independently associated with the severity of liver fibrosis in chronic HCV infection.
引用
收藏
页码:134 / 137
页数:4
相关论文
共 15 条
[1]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[2]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[3]   Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection [J].
Bierhoff, E ;
Fischer, HP ;
Willsch, E ;
Rockstroh, J ;
Spengler, U ;
Brackmann, HH ;
Oldenburg, J .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 430 (04) :271-277
[4]  
BONACINI M, IN PRESS ARCH INT ME
[5]  
DAVIS GL, 1994, HEPATOLOGY, V19, P1337, DOI 10.1002/hep.1840190603
[6]   Hepatitis C [J].
Di Bisceglie, AM .
LANCET, 1998, 351 (9099) :351-355
[7]  
Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
[8]   CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION [J].
MIEDEMA, F ;
MEYAARD, L ;
KOOT, M ;
KLEIN, MR ;
ROOS, MTL ;
GROENINK, M ;
FOUCHIER, RAM ;
VANTWOUT, AB ;
TERSMETTE, M ;
SCHELLEKENS, PTA ;
SCHUITEMAKER, H .
IMMUNOLOGICAL REVIEWS, 1994, 140 :35-72
[9]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[10]   Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C:: a comparison between immunocompetent and immunocompromised patients [J].
Pol, S ;
Fontaine, H ;
Carnot, F ;
Zylberberg, H ;
Berthelot, P ;
Bréchot, C ;
Nalpas, B .
JOURNAL OF HEPATOLOGY, 1998, 29 (01) :12-19